Shares of Johnson & Johnson (NYSE: JNJ) recently traded at $218.61, surpassing the average 12-month analyst target price of $213.83. This price movement prompts analysts to consider adjusting their target ratings, which currently range from as low as $165.00 to as high as $240.00, with a standard deviation of $20.17.
The Zacks coverage group reports 24 analyst targets for JNJ; 13 analysts rated it as a Strong Buy, 2 as Buy, 10 as Hold, and none as Sell or Strong Sell, resulting in an average rating of 1.88 on a scale where 1 represents Strong Buy.
